PERS Genetic Model Assistant Decision-making System of Neoadjuvant Chemotherapy for Breast Cancer

NCT03006614 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

320

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer Model
Effects of Chemotherapy
Breast Cancer

Interventions

DRUG: NVB
DRUG: EPI
DRUG: DDP
DRUG: CAP
DRUG: GEM
DRUG: H
DRUG: CTX
DRUG: T

Sponsor

Shi Yanxia